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Abstract
Background: Human papillomaviruses (HPVs) are genetically diverse, belonging to five distinct genera: Alpha, Beta,
Gamma, Mu and Nu. All papillomaviruses have double stranded DNA genomes that are thought to evolve slowly
because they co-opt high-fidelity host cellular DNA polymerases for their replication. Despite extensive efforts to
catalogue all the HPV species that infect humans, it is likely that many still remain undiscovered. Here we use the
sequences of ten novel Gammapapillomaviruses (Gamma-PVs) characterized in previous studies and related HPVs to
analyse the evolutionary dynamics of these viruses at the whole genome and individual gene scales.
Results: We found statistically significant incongruences between the phylogenetic trees of different genes which
imply gene-to-gene variation in the evolutionary processes underlying the diversification of Gamma-PVs. We were,
however, only able to detect convincing evidence of a single recombination event which, on its own, cannot explain
the observed incongruences between gene phylogenies. The divergence times of the last common ancestor (LCA)
of the Alpha, Beta, Mu, Nu and Gamma genera was predicted to have existed between 49.7–58.5 million years ago,
before splitting into the five main lineages. The LCA of the Gamma-PVs at this time was predicted to have existed
between 45.3 and 67.5 million years ago: approximately at the time when the simian and tarsier lineages of the
primates diverged.
Conclusion: Consequently, we report here phylogenetic tree incongruence without strong evidence of recombination.
Keywords: Human papillomavirus, Gamma-PVs, Most recent common ancestor, Phylogenetic incongruence,
Recombination, Molecular divergence
Background
Human papillomavirus (HPV) is a member of the Papillo-
maviridae family [1, 2] which was once part of the larger
family of Papovaviridae which was split into Polyomaviri-
dae and Papillomaviridae by the International Committee
on Taxonomy of Viruses (ICTV) [3]. There are currently
29 genera in the Papillomaviridae family named according
to the Greek alphabet from alpha to omega and following
exhaustion of the alphabet the term dyo-(Greek for second
time) coined to accommodate the extra genera e.g. dyo-del-
tapapillomaviruses [1]. HPVs are distributed over 5 genera
(Alpha, Beta, Gamma, Mu and Nu). The other papillomavi-
rus (PV) genera are from other mammals (20), birds (3)
and reptiles (1) [1]. Below the genus level are species and
below the species level are types [2]. The ICTV is respon-
sible for nomenclature of viruses down to species level, and
below species level, the International HPV Reference
Centre in Stockholm Sweden assigns unique HPV type
numbers after the complete genome has been sequenced,
cloned and confirmed by the Centre [4]. The recognition of
a novel HPV type by the International HPV Reference
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Centre and the scientific community is based on availability
of the full cloned genome, with the L1 gene sequence
greater than 10% different or < 90% similar from any previ-
ously described type [1].
HPVs are thought to evolve slowly because they repli-
cate by co-opting high fidelity host cellular DNA poly-
merases that have an error rate of about 4.3 × 10− 5
substitutions per nucleotide site per year [5]. It is there-
fore generally assumed that HPVs have co-evolved with
their hosts [6–8]. However, several host factors may
affect HPV evolutionary rates over time; for example,
the cellular protein APOBEC3 cytidine deaminase may
result in nucleotide compositional biases that contribute
to cytosine containing codons accruing more frequently
that thiamine containing codons. Selection pressures
due to cellular or humoral immune responses may also
differ between genes and result in these genes displaying
different substitution rates. Further, the cellular polymer-
ases of different host species may differ in their degree
of fidelity such that virus lineages infecting different
hosts might display different substitution rates [9].
It has been estimated that PVs appeared about 250–150
million years ago [10] in the Mesozoic age (age of reptiles/
dinosaurs) [6]. Whereas the most recent common ances-
tor (MRCA) of the Alpha, Beta, Gamma, Mu and Nu
HPVs has been inferred to have existed between 30 and
50 MYA [11], the MRCA of the present day Gamma-PVs
has been inferred to have existed between 15 and 30 MYA
[11]. The evolutionary rate of PVs has been estimated
from feline-PVs to be about 1.95 × 10− 8 nucleotide substi-
tutions per site per year [12].
The discovery of numerous new PVs using deep sequen-
cing methods has begun to shed further light on the evo-
lutionary history of this virus family. However, unravelling
the evolutionary history of these viruses is potentially
complicated by both inter-gene phylogenetic incongru-
ence and recombination [13]. It has been observed that
the nucleotide and encoded amino acid sequences of the
E and L genes have evolved slightly differently in terms of
evolutionary rate and selection pressures [14, 15]: a factor
that could contribute to phylogenetic incongruence be-
tween the E and L gene trees. As a consequence of this,
no single gene tree will accurately and adequately repre-
sent the evolutionary history of complete papillomavirus
genomes [13]. Recombination events between different
PVs may provide an additional explanation for gene-to-
gene phylogenetic incongruence.
The biological plausibility of PV recombination is occa-
sioned by the genetic diversity of PVs and the high fre-
quencies of observed HPV co-infections [16]. However, the
study of PV recombination has been hampered by tech-
nical difficulties associated with the accurate alignment of
highly diverse PV gene sequences [17]. One of the most
commonly used approaches to recombination detection is
the use of the various recombination analysis tools imple-
mented within the RDP4 software package [18]. During re-
combination detection, RDP4 rigorously tests the quality
of sequence alignments to guard against the detection of
false-positive recombination signals that arise due to se-
quence misalignment [19].
We report here on the use of sequences of ten novel
Gamma-PVs characterized in a previous studies [20, 21],
and related HPVs to analyse the evolutionary dynamic of
these viruses at the whole genome and individual gene
levels. Specifically, we use phylogenetic tree incongru-
ence tests to identify incongruence and direct recombin-
ation tests to determine whether observed phylogenetic
incongruences might be linked to recombination. We
further use the novel sequences to estimate the likely
times of the MRCA of the Gamma-PVs.
Methods
Source of sequence data
Sequences were downloaded from the Papillomavirus epis-
teme (PAVE) database (https://pave.niaid.nih.gov accessed
on 27/01/2018). The sequences for HPV211-HPV216 and
HPV219-HPV222 were obtained from our group [20, 21] .
The novel HPV DNA sequences were deposited in Gen-
bank under the following accession numbers: HPV211
MF509816, HPV212 MF509817, HPV213 MF509818,
HPV214 MF509819, HPV215 MF509820, and HPV216
MF509821. The GenBank accession numbers for HPV219,
HPV220, HPV221, HPV222 genomes are MH172376,
MH172377, MH172378, MH172379, respectively. PVs are
classified by the International Committee on Taxonomy of
Viruses (ICTV) into distinct species, but the nomenclature
of types can be done by specific working groups. Some of
the viruses used in this study are pending classification by
the ICTV, but were provisionally grouped into specific gen-
era and types by the HPV reference centre in Sweden
(http://www.nordicehealth.se/hpvcenter/reference_clones/).
Phylogenetic incongruence testing
The Shimodaira-Hasegawa test [22] using W-IQ-TREE [23]
We used clustal alignments [24–26] of E1, E2, E4, E7,
L1 and L2 HPV genes from 80 Gamma-HPVs (including
the ten novel types) to compute the log-likelihoods of
phylogenetic trees in W-IQ-TREE, which is a fast online
phylogenetic tool for maximum likelihood analysis
(http://iqtree.cibiv.univie.ac.at) [23]. The tool test tree
topology estimates model parameters such as substitu-
tion rates and optimizes tree branch lengths to lessen
computational usage. We used default settings of the
W-IQ-Tree, including best fit model [27] and ultra-fast
bootstrap analysis (1000 alignments) [28] to run tree
topology analysis including the Kishino-Hasegawa (KH)
test [29], Shimodaira-Hasegawa (SH) test [22] and
approximately unbiased (AU) test [30] to test if there is
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a difference in evolutionary patterns amongst the differ-
ent HPV genes.
Recombination analysis
Eighty complete Gamma-PV genomes that are representa-
tive of all currently known Gamma-PVs were obtained
from the PAVE database, including the ten novel HPV
types recently discovered and genomically characterised by
our group [20, 21] . All genomes were linearized at the first
nucleotide position of their E6 genes except for Gamma
species 6 viruses that lack E6 and for which the start was
shifted to the first nucleotide of their E7 genes. We then
constructed an alignment containing the 80 Gamma-PVs
using MUSCLE. This alignment was analysed using RDP
v4.95 [18] (with default settings) which implements ana-
lysis of recombination using several methods: RDP [18],
BOOTSCAN [31], CHIMAERA [32], GENECONV [33],
MAXIMUM X2 [34] and SISCAN [35].
Construction of a time-scaled HPV phylogeny
We sought to infer the probable divergence times of our
newly characterised HPV types from currently known
HPVs. The complete L1 nucleotide sequences from 214
PV sequences were selected for analysis (Table 1). Two
avian PVs: FcPV (Fringilla coelebs, the common chaf-
finch), PePV (Psittacus erithacus, the grey parrot); one
turtle PV: CcPV1 (Caretta caretta, the loggerhead turtle)
and one bovine PV (BPV1) were also included in the
analysis as outgroups. We performed a Bayesian evolu-
tionary molecular clock analysis using BEAST v1.8.4 [36]
with a GTR + I + G nucleotide substitution model and an
uncorrelated lognormal relaxed clock model. A fixed
mean substitution rate for HPVs was applied based on
estimated evolutionary rates inferred from prior studies
that investigated the divergence times of feline PVs
(1.95 × 10− 8 nucleotide substitutions per site per year)
[12]. The Markov Chain Monte Carlo (MCMC) analysis
was run for 100,000 million generations with sampling
every 10,000 generations. The final MCMC sampling
chains were visually assessed for convergence and good
mixing using Tracer v1.7.1 [37]. A Maximum Clade
Credibility (MCC) tree was generated after discarding
the first 1000 trees that were obtained prior to the
burn-in period of the chains.
Results
Phylogenetic incongruence among novel Gamma-PVs
gene trees
To determine if the phylogenetic trees for different
Gamma-PV genes were congruent, we used a more con-
clusive test, the SH test [22]. The null hypothesis of the
SH test states that the difference between trees (branch
length, topology or likelihoods) is zero. The observed
differences (deltaL values) are significantly greater than
zero and the null hypothesis was rejected, thus declaring
that the trees are significantly different i.e. incongruent
(p < 0.05). Table 2 shows the results of the SH test using
W-IQ-Tree, indicating that there is substantial phylo-
genetic incongruence between the late and early genes
of Gamma-PVs as shown by the p-values (p-SH).
Recombination analysis
The Gamma-PV whole genome alignments contained a
total of only three plausible recombination events,
namely: events 1, 2 and 3. These events were all detect-
able by two or more different recombination detection
methods with a p-value cut-off < 0.05. However, event 1
and event 2 had no phylogenetic support and were
therefore disregarded. Event 3 suggests that HPV4 and
its near relatives all share evidence of the same ancestral
recombination event [21] Table 3.
The time-scale of Gamma-PVs evolution
A fixed mean substitution rate for HPVs was applied
based on estimated evolutionary rates inferred from of
feline PVs (1.95 × 10− 8 nucleotide substitutions per site
per year) [19]. The divergence times of the MRCA of
HPV was predicted to have occurred 53.9 MYA (95%
HPD 49.7–58.5), before splitting into the five main po-
tential ancestors (Alpha, Beta, Mu, Nu and Gamma gen-
era). The MRCA of the present-day Gamma-PVs was
predicted to have occurred approximately 49.8 MYA
(95% HPD 45.3–67.5). The novel HPV 212 was pre-
dicted to have diverged from its closest relative,
HPV144, about 7.6 MYA (95% HPD 5.2–10.4), diver-
gence times from the MRCA of the remaining nine
novel Gamma-PVs are shown in Table 4. The predic-
tions lie between 7.6 to 19.9 MYA.
It has been reported that between 10 and 20 MYA, sev-
eral hominoid precursors lived in Africa, Europe and Asia
[40] and the timing and spatiotemporal patterning of the
Table 1 Summary of Analysis Performed and sequence dataset used
Type of analysis Sequence data set used
Shimodaira-Hasegawa test 80 whole genomes of currently known Gamma-HPVs
Recombination analysis 80 whole genomes of currently known Gamma-HPVs
Construction of a time-scaled HPV phylogeny 214 L1 nucleotide sequences of mostly HPV sequences and 2 avian PVs, one turtle PV and
one bovine PV
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Table 2 Shimodaira-Hasegawa test for incongruence
E1 as reference tree
Tree deltaL bp-RELL p-KH p-SH p-WKH p-WSH c-ELW p-AU
E1 0 1 1 1 1 1 1 0.999
E2 182.16 0 0 0.008 0 0 7.3e-33 0.000747
E4 639.14 0 0 0 0 0 3.8e-203 0.000845
E7 1048.70 0 0 0 0 0 0 1.8e-58
L1 381.21 0 0 0 0 0 3.8e-104 4.2e-05
L2 219.47 0 0 0.002 0 0 1.2e-40 2.4e-09
E2 as reference tree
Tree deltaL bp-RELL p-KH p-SH p-WKH p-WSH c-ELW p-AU
E1 137.43 0 0 0.023 0 0 1.3e-27 8.3e-05
E2 0 1 1 1 1 1 1 1
E4 288.35 0 0 0 0 0 1.3e-75 2.8e-07
E7 904.92 0 0 0 0 0 3.4e-299 6.7e-97
L1 273.21 0 0 0 0 0 5.9e-70 5.7e-44
L2 224.96 0 0 0 0 0 1.8e-60 5.1e-07
E4 as reference tree
Tree deltaL bp-RELL p-KH p-SH p-WKH p-WSH c-ELW p-AU
E1 79.74 0 0 0.012 0 0.004 0.000433 0.0217
E2 64.99 0.02 0.003 0.02 0.003 0.016 0.00211 0.104
E4 0 0.998 0.997 1 0.997 1 0.997 0.992
E7 311.86 0 0 0 0 0 8.7e-85 5.8e-114
L1 130.15 0 0 0 0 0 1.2e-23 6.4e-35
L2 84.83 0 0 0.004 0 0 1.1e-10 0.00483
E7 as reference tree
Tree deltaL bp-RELL p-KH p-SH p-WKH p-WSH c-ELW p-AU
E1 59,374 0.004 0.016 0.017 0.016 0.064 0.00429 0.0117
E2 71.02 0.001 0.007 0.007 0.007 0.031 0.000919 0.00182
E4 138.43 0 0 0 0 0 1.78e-20 0.014
E7 0 0.946 0.952 1 0.952 0.991 0.944 0.945
L1 39.42 0.0041 0.048 0.119 0.048 0.189 0.043 0.118
L2 59.86 0.008 0.022 0.025 0.022 0.063 0.00759 0.0321
L1 as reference tree
Tree deltaL bp-RELL p-KH p-SH p-WKH p-WSH c-ELW p-AU
E1 188.69 0 0 0 0 0 1.3e-25 7.6e-05
E2 218.51 0 0 0 0 0 4.1e-40 6.6e-48
E4 473.21 0 0 0 0 0 1.6e-133 0.000267
E7 899.66 0 0 0 0 0 3.5e-301 5.98e-65
L1 0 1 1 1 1 1 1 1
L2 149.83 0 0 0.005 0 0 9.9e-301 1.23e-10
L2 as reference tree
Tree deltaL bp-RELL p-KH p-SH p-WKH p-WSH c-ELW p-AU
E1 226.34 0 0 0 0 0 2.4e-51 1.3e-52
E2 220.29 0 0 0 0 0 1.8e-50 8.4e-12
E4 478.78 0 0 0 0 0 1.5e-149 4.2e-06
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disappearance of Neanderthal human precursors has only
been radiocarbon dated to a limit of 50,000 years ago [41].
Thus, our MRCA prediction suggests that all the current
HPV species diverged from what are currently their near-
est relatives before the origin of humans.
The MRCA of the Gamma-6 species was predicted to
have existed 22 MYA (95% HPD 17.7–27.3) earlier than
that of most other Gamma-PVs species. The MRCA of all
other Gamma-species viruses and the Gamma-6 viruses
was predicted to have occurred 46.8 MYA (95% HPD
42.9–51.3). The rest of the node divergence times are
shown in Fig. 1 with the 95% highest posterior densities.
Discussion
Phylogenetic incongruence and recombination
An analysis of phylogenetic trees generated from different
genes of the ten novel South African Gamma-PVs and
their closest known relatives indicated differences, ranging
from slight to major, between the branch lengths and
branching orders of phylogenetic trees constructed from
different genes. Differences between internal branches of
phylogenetic trees constructed using different parts of the
same HPV genomes have been described extensively else-
where [6, 42, 43]. These differences could imply the occur-
rence of recombination, as has been previously reported
[44]. Different PV genes have been shown to have different
evolutionary rates, with an overall rate of 1.95 × 10− 8 and
a range of 1.76 × 10− 8 to 2.69 × 10− 8 substitutions/site/
year [13]. The PV genome has a modular nature, which is
evident today in the different evolutionary rates of the dif-
ferent genes, the new genes E5, E6 and E7 encoding onco-
proteins diverge faster than the old four genes E1, E2, L2
and L1 [15]. The four old proteins are by themselves able
to fulfil the basic tasks of replication, regulation, stabilisa-
tion and viral DNA packaging leading to vegetative release
of viral progeny from host cells [45]. The acquisition of
the new oncogenes has introduced two PV phylogenies,
high risk Alpha-PVs cluster together according to the
phylogeny of these oncogenes (E5, E6, E7) but they do not
cluster together according to the phylogeny of the capsid
proteins (L1 and L2) [42]. Additionally, the number of
mutations are higher in the new oncogenes than in most
of the PV genes [42]. It is thus proposed that the history of
PVs took place in different stages, the first stage represents
Table 2 Shimodaira-Hasegawa test for incongruence (Continued)
E7 1087.1 0 0 0 0 0 0 0.00124
L1 229.72 0 0 0 0 0 1.3e-42 2.01e-13
L2 0 1 1 1 1 1 1 1
deltaL: logL difference from the maximal logl in the set
bp-RELL: bootstrap proportion using RELL method [38]
p-KH: p-value of one sided [29]
p-SH: p-value of Shimodaira-Hasegawa test [22]
p-WKH: p-value of weighted KH test
p-WSH: p-value of weighted SH test
c-ELW: Expected Likelihood Weight [39]
p-AU: p-value of approximately unbiased (AU) test [30]





Parent sequence Evidence (method with
P value < 0.05)
Intra-species or inter
species recombination
In Alignment In Genbank
sequence
Minor (Gamma-species) Major (Gamma-species)







N.B Only event 3 is shown in Table 2, all the potential recombinant Gamma-PVs for this event are shown in the recombinant column and the proposed major and
minor parents
^ = The recombinant sequence may have been misidentified (one of the identified parents might be the recombinant
Minor Parent = Parent contributing the smaller fraction of sequence
Major Parent = Parent contributing the larger fraction of sequence
Unknown = only one parent and a recombinant need be in the alignment for a recombination event to be detectable the sequence listed as unknown was used
to infer the existence of a missing parental sequence
[T] Sequences with trace evidence of the same recombinant event
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the initial appearance of a prototype-PV with the cardinal
genes (E1, E2, L2 and L1) found in all PVs. Then second
stage involved further divergent evolutionary processes
that led to the acquisition of the E5, E6 and E7 oncopro-
teins, and these newly acquired proteins evolved about
two times faster than the core region of the genome [15].
It has been observed that the genes and encoded amino
acid sequences of viral early and late proteins have evolved
differently in terms of evolutionary rate and selection
pressure [14, 15], and hence the incongruence between
early and late trees. PV recombination events may provide
a clue to the phylogenetic incongruence, but recombin-
ation is not the only explanation for this incongruence.
We did not, however find strong evidence of recom-
bination among Gamma-HPV types. From the 80 full
Gamma-PVs (70 known HPV types and the ten novel
types) included in the analysis only one strongly sup-
ported recombination event was detected. Recombin-
ation in Gamma-PVs has been reported elsewhere [46].
In that study, seven potential recombination events were
reported using separate analyses of individual genes (ra-
ther than analysing full genomes). We detected few
Gamma-PVs recombination events. Varsani et al. (2006)
[19] reported 529 potential recombination events, yet
only ten were true events. The phenomenon is not
exclusive to Gamma-PVs, in Alphapapillomaviruses re-
combination events have been well described [16, 47].
The difficulty of detecting recombination events in PVs
relates to the technical difficulty of aligning highly diver-
gent DNA sequences [6, 16, 19]. Another factor is that
most recombination detection methods are only designed
to detect recombination events when one or both of the
parental sequences have close relatives represented in the
dataset being analysed [13]. Therefore, as more PVs are
discovered it becomes more likely that sequences closely
related to the parents of recombinants will be included in
recombination analyses. We also only included Gam-
ma-PVs, in our recombination analysis dataset and our
analysis was therefore only powered to detect for evidence
of intra-genus recombination. However, this is probably
not a major issue since the only convincing evidence of re-
combination in PVs that has so far been published has
been between PVs in the same genus [47]. We have previ-
ously reported that the ten novel Gamma-PVs are under
no positive selection pressure but rather purifying selec-
tion (dn/ds < 1) ([21].
It has been shown elsewhere that different PV genes are
under different selection pressures [48] and also that dif-
ferent genes have different evolutionary rates ranging be-
tween 2 × 10− 8 and 5 × 10− 9 substitutions per site per year
[12, 44]. Thus, no single gene tree will accurately repre-
sent the evolutionary history of entire PV genomes [13].
Consequently, we report here phylogenetic tree incon-
gruence with no evidence of recombination. It has been
proposed that in such scenarios there is convergent as op-
posed to divergent evolution [49]. Convergent evolution
can be defined as the independent evolution of similar fea-
tures or characteristics in species of different lineages.
Temporal evolution within Gamma-PVs
We show here that the MRCA of HPV was predicted to
have occurred about 50–60 MYA. This is comparable to
work done by Chen et al. (2007) [11], and that the
MRCA of the Gamma-PVs existed about 45–67 (49.8)
MYA. Further, we were able to show that within the
Gamma-PV genus, the Gamma-6 species split from the
rest of all the other Gamma species about 43–51 (46.8)
MYA, while Van Doorslaer and Mcbride (2016) [50]
showed that Gamma-6 species last shared a common
ancestor with other Gamma-PVs around 60 MYA. Fur-
ther, we showed that the MRCA of the Gamma-6 species
occurred about 22 MYA, which concurs with Van Door-
slaer and Mcbride (2016) [50] who reported that the
Gamma-6 species MRCA existed 23.4 MYA. Therefore,
we hypothesise that the Gamma-6 species lost the E6
gene between 20 and 60 MYA. This suggests that E6
was lost before the evolution of hominoid primates be-
tween 10 and 20 MYA [40]. This implies two things: 1)
Table 4 Mean divergence time of 10 novel HPVs from other gamma species or closest relative
HPV types Gamma-Species Posterior Mean Divergence Time (95% Highest Posterior Density) from MRCA
HPV211 8 1 19.9 (16.8–23.1) from all other Gamma-8 species HPV types
HPV212 17 1 7.6 (5.2–10.4) from its closest relative HPV144
HPV213 13 1 5.4 (4.0–7.1) from its closest relative HPV219
HPV214 6 1 17 (12.8–20.7) from closest relatives HPV108 and HPV103
HPV215 9 1 11.3 (9.2–13.7) from closest relative HPV216 and HPV129
HPV216 9 1 8.3 (6.2–10.6) from closest relative HPV129
HPV219 13 1 5.4 (4.0–7.1) from its closest relative HPV219
HPV220 17 1 19.9 (15.1–23.0) from all other Gamma-17 species HPV types
HPV221 10 1 8.3 (5.8–11.5) from closest relative HPV142
HPV222 19 1 19.2 (15.7–23.0) from all other Gamma-19 species HPV types
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Fig. 1 Molecular divergence times of PVs. A fixed mean substitution rate for HPVs was applied based on estimated evolutionary rates inferred from a
study that investigated the times to the MRCA based of feline papillomaviruses (1.95 × 10− 8 nucleotide substitutions per site per year) [12]. Classification
was based on [1, 2]. Posterior support values and exact divergence estimates in million years (with 95% highest posterior density) for the nodes
corresponding to the 10 HPV types are presented in Table 2, the novel types are indicated in red
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that viruses lacking E6 may infect old world and new
world monkeys, suggesting that it could be productive to
hunt for these viruses in primates, and 2) that the
E6-minus viruses co-evolved with their hosts over a long
enough period of time for us to have been able to isolate
them from current humans (assuming papillomaviruses
species specificity). Chen et al. (2007) [11] had previ-
ously predicted the loss of the E6 gene to have occurred
about 15–30 MYA, the estimate was based only on the
L1 open reading frame (ORF) of nine divergent papillo-
maviruses. Here, we have estimated this date using 214
papillomavirus L1 nucleotide sequences from all the
genera containing HPV sequences.
PVs lacking E6 have also been described in parrots
(PePV1), donkeys (EaPV1) and bovines [51]. Presently, 7
known human PVs of the Gamma-6 species lack the E6.
The size of E6 (mean 253.5 nt) in the genomes of PVs in-
fecting birds and turtles is about half the size that it is in
mammal-infecting PV genomes (mean 438 nt) [51]. The
larger size of the mammalian PV E6 accommodates a
second E6 zinc finger binding motif domain [52]: a do-
main that was possibly the result of duplication of an an-
cestral E6 motif [53]. E6 mediated p53 degradation has
been described as one of the hallmarks of HPV mediated
carcinogenesis, and the presence of this double motif
may explain the increased likelihood of HPVs in causing
cancer compared to PVs infecting birds and turtles.
Gamma-PVs lack an E5 gene, which is located be-
tween the early genes and the late genes and is thought
to have evolved originally from a non-coding region that
was integrated between the early and the late genes of
an ancestral sequence belonging to the Alphapapilloma-
viruses lineage [51]. Willem et al. also suggest that inte-
gration of E5 in this region promoted an adaptive
radiation which yielded E6 and E7 proteins capable of
degrading tumour suppressor proteins and facilitating
carcinogenesis [51]. This is supported by the fact that 1)
E6 and E7 proteins in Alpha PVs (together with E5) have
greater oncogenic potential as classified by IARC as
compared to the E6 and E7 of Gamma-PVs (that lack
E5) and 2) E5 has an evolutionary rate that is approxi-
mately twice that of the remainder of the PV genome
[54]. The integration of the E5 ORF was predicted to
have occurred in an ancestral virus that existed 30–60
MYA (in the Cenozoic era) which eventually gave rise to
the Alpha. Mu and Nu lineages; each of which has dif-
ferent cell tropisms and clinical manifestations [6].
Willem et al. [51] inferred the appearance of the E5
oncogene occurred 53–58 MYA: well within the range
of that predicted by Bravo et al. [6].
We also reported the acquisition of E10 in HPV214
[21], which we hypothesised coincided with E6 loss as
previously reported [55]. We speculate that if the loss of
E6 occurred 20–60 MYA then E10 was acquired a few
million years later or that the loss and gain might have
occurred concurrently as a modification of E6 to E10.
This is supported by the fact that the E10 ORF overlaps
with the more conserved portion of the E6 scar [50].
We report divergence times from 7.6 to 20 MYA with
most lying well within the origin times of many other
known PVs. However, HPV211 of the Gamma-8 species
branches earlier from the other five HPV types in this
species, i.e., the MRCA of HPV211 and the other 5
Gamma-8 species types is predicted to have occurred 20
MYA. This implies that HPV211 is closer to the ances-
tral or parental sequence of Gamma-8 species compared
to HPV112, HPV119, HPV168, HPV147, and HPV164,
and hence, it is more likely to be major/minor parent
than it can be a recombinant. The MRCA of HPV222
and the other 3 members of the Gamma-19 species is
19.2 MYA. HPV222 branches from HPV161, HPV162
and HPV166 earlier than the others, also making it
closer to the ancestral or parental sequence of the
Gamma-19 species.
Conclusion
In this work, we report the evolutionary characterisation
of Gamma-PVs including that of the novel HPV types. To
get a deeper insight into the evolutionary processes that
may influence the diversification of Gamma-PVs, we
explored phylogenetic incongruences among different
genes of the novel types, attempted to discover potential
recombination events between all known Gamma-PVs,
and also estimated the time scale for Gamma-PVs evolu-
tion. Consequently, we report here phylogenetic tree in-
congruence without strong evidence of recombination.
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